Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

New collaboration focused on using AI to improve the speed, accuracy of cancer care

By Author Proscia | March 3, 2020

Proscia, a Philadelphia-based AI technology company, has partnered with the University of California, San Francisco (UCSF) to improve cancer diagnoses and improve patient outcomes.

The collaboration will begin with an emphasis on prostate cancer, an especially fatal disease among men in the United States, but it will go on to cover other key areas of interest as well.

Our website uses cookies. By using this site, you agree to its use of cookies.